发明名称 Polymeric gel delivery system for pharmaceuticals
摘要 Implantable, injectable, insertable, or otherwise administrable compositions that form hydrogels when implanted, injected, inserted, or administered into or onto living tissues comprise a pharmaceutically effective compound wherein the pharmaceutically effective compound is a codrug, or pharmaceutically acceptable salt or prodrug thereof in admixture with a hydrogel-forming compound. The pharmaceutically effective compound may be any compound that is soluble in bodily fluids, or that forms bodily fluid-soluble adducts when exposed to bodily fluids. Exemplary compounds include analgesic, anti-inflammatory and antibiotic compounds. The hydrogel-forming compound is a biologically tolerated substance that forms a hydrogel upon exposure to bodily fluids, such as the interstitial fluid surrounding or within a joint.
申请公布号 US2009010986(A1) 申请公布日期 2009.01.08
申请号 US20080229943 申请日期 2008.08.28
申请人 PSIVIDA, INC. 发明人 ASHTON PAUL;CHEN JIANBING
分类号 A61F2/04;A61K9/20;A61K9/00;A61K9/16;A61K9/48;A61K31/196;A61K31/407;A61K31/485;A61K31/58;A61K45/08;A61K47/08;A61K47/12;A61K47/32;A61K47/34;A61K47/36;A61K47/38;A61K47/42;A61P9/00;A61P25/02;A61P25/04;A61P25/06;A61P27/06;A61P29/00;A61P31/04;A61P31/12;A61P35/00;A61P37/02;A61P43/00 主分类号 A61F2/04
代理机构 代理人
主权项
地址